Nelsen Robertinsider trades
In SEC Form 4 filings, Nelsen Robert is listed as Director, 10% owner of City Therapeutics, Inc. (CTY). In the last 90 days, Nelsen Robert bought $3.06M of City Therapeutics, Inc. (CTY) on the open market and sold none. The purchase was $3.06M of City Therapeutics, Inc. (CTY) on Oct 19. Took part in a cluster buy; the latest at City Therapeutics, Inc. (CTY), where 2 insiders bought within 1 day, ending Oct 19.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| CTYCity Therapeutics, Inc. | Director, 10% owner | 8 | Oct 19 |
Cluster buys
- CTY: 2 insiders bought $6.12M between Oct 19.
Form 4 historysince 2026-10-19
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CTYCity Therapeutics, Inc. | Oct 19 | Oct 19 | C | 3,294,900 | not reported | not reported | 6,013,192 | No | Form 4 |
| CTYCity Therapeutics, Inc. | Oct 19 | Oct 19 | C | 5,482,309 | not reported | not reported | 11,495,501 | No | Form 4 |
| CTYCity Therapeutics, Inc. | Oct 19 | Oct 19 | C | 2,027,006 | not reported | not reported | 13,522,507 | No | Form 4 |
| CTYCity Therapeutics, Inc. | Oct 19 | Oct 19 | P | 170,000 | $18.00 | Purchase +$3,060,000 | 13,692,507 | No | Form 4 |
| CTYCity Therapeutics, Inc. | Oct 19 | Oct 19 | C · derivative | 3,000,000 | $0.00 | $0 | not reported | No | Form 4 |
| CTYCity Therapeutics, Inc. | Oct 19 | Oct 19 | C · derivative | 4,991,633 | $0.00 | $0 | not reported | No | Form 4 |
| CTYCity Therapeutics, Inc. | Oct 19 | Oct 19 | C · derivative | 1,845,585 | $0.00 | $0 | not reported | No | Form 4 |
| CTYCity Therapeutics, Inc. | Oct 15 | Oct 19 | A · derivative | 22,649 | $18.00 | $407,682 | 22,649 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.